New targeted therapies in spondyloarthritis: what are the limits?
| Affiliation auteurs | !!!! Error affiliation !!!! |
| Titre | New targeted therapies in spondyloarthritis: what are the limits? |
| Type de publication | Journal Article |
| Year of Publication | 2019 |
| Auteurs | Wendling D |
| Journal | IMMUNOTHERAPY |
| Volume | 11 |
| Pagination | 557-560 |
| Date Published | MAY |
| Type of Article | Editorial Material |
| ISSN | 1750-743X |
| Mots-clés | anti-IL-17, anti-IL-23, anti-TNF, JAK inhibitors, Spondyloarthritis, treatment |
| Résumé | ``It would be interesting to acquire knowledge about predictive factors of good clinical response for each of these treatments. This would allow a more accurate decision on treatment initiation and a trend to personalized medicine. This may be achieved by retrospectively analyzing the data of randomized controlled trials and their extensions, as well as those from real-life cohorts.'' |
| DOI | 10.2217/imt-2019-0007 |